43 /100
MEDIUM RISK
Score updated Jul 13, 2026

KYNB — Kyntra Bio, Inc. Dilution Risk Tracker

Track KYNB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track KYNB — Get alerts when the score changes →

As of July 13, 2026, Kyntra Bio, Inc. (KYNB) has a DilutionWatch DilutionScore of 43/100, rated MEDIUM dilution risk. Kyntra Bio, Inc. has a market capitalization of $27.93M, 4.05M shares outstanding, 34 institutional holders tracked. Key dilution vectors include approximately 6 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
36
💰 Cash Runway
65
📊 Float Risk
15
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
7%
💰 Capital Raise 15%
• Under 12 months cash (6mo)
🔔 Track KYNB — Get forecast alerts →

💹 Market Data

Market Cap$27.93M
Shares Outstanding4.05M
Float3.56M
Cash$87.24M
Debt$75.00M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 10.1% shares (2026Q1 vs prior)
34 institutional holders · 1.30M shares
#1 ARMISTICE CAPITAL, LLC 400.0K shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 313.2K shares
#3 ACADIAN ASSET MANAGEMENT LLC 105.6K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest109.5K
Days to Cover6.4
% of Float3.1%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2015
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for KYNB Shareholders

Kyntra Bio, Inc. (KYNB) has a DilutionScore of 43/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 13, 2026.

Cash runway is a key watch item: KYNB has approximately 6 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for KYNB in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for KYNB alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track KYNB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking KYNB — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for KYNB
📊 KYNB FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 KYNB Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.